Protocol number: APD334-303 An Open-Label Extension Study of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis ELEVATE UC OLE: An Open-Label Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis. ARENA APD334-303. Lilly, Sub-Investigator - Faz 3